Exits
10 stories covering exits — fund closes, LP allocations, regulatory filings, deal flow, and fundraising signals from PipelineRoad's editorial team.
Private Equity Exits Decline in Early 2026 Due to AI Volatility and Geopolitical Tensions
Private equity firms reduced asset sales by 36% in Q1 2026 amid AI-driven market volatility and conflicts involving Iran, according to a report.
Bank of America Launches Private Capital M&A Group for PE Exits
Bank of America has established a new Private Capital M&A Group to address demand for flexible exit options in private equity, as reported by Private Equity Wire.
Asia-Pacific Private Equity Sees Exit Rebound and Positive Net Distributions in 2026
Bain & Company's report indicates rebounding exit values and positive net cash flows signaling investor confidence in Asia-Pacific private equity for 2026.
Asia-Pacific Private Equity Signals Optimism in 2026 with Exit Rebound
Bain & Company's report highlights improving liquidity and positive net distributions in Asia-Pacific private equity for 2026, amid challenges in deal value and fundraising.
Swarmer's IPO and Defense Tech Exits
Venture Capital Journal discusses whether Swarmer's drone software IPO signals broader exits for defense tech firms or benefits only select VCs.
Swarmer's IPO Prompts Debate on Defense Tech Exits
The IPO of drone software maker Swarmer raises questions about potential waves of exits in the defense tech sector, as discussed in a Venture Capital Journal article.
Ardian, CVC, Verdane Eye Investments in Women’s Health; Exellere, GHO Exit Pathology Services Deal
Private equity firms Ardian, CVC, and Verdane target women’s health investments, while Exellere and GHO sell a pathology services company for $950 million.
Ardian, CVC, Verdane Target Women’s Health Investments; Exellere, GHO Exit Pathology Deal
Private equity firms Ardian, CVC, and Verdane are eyeing investments in women’s health, while Exellere Partners and GHO Capital Partners sell a pathology services company for $950 million.
Clog in PE's Exit Pipeline Becomes Tougher to Clear
Buyouts Insider reports that even private equity assets from less frothy market eras are proving difficult to sell.
Private Equity Exit Pipeline Clogs Further, Assets Hard to Sell
Buyouts Insider reports that private equity's exit pipeline is getting tougher to clear, with even assets from less frothy market eras proving difficult to sell.
